181 related articles for article (PubMed ID: 36126056)
1. Novel AAV-mediated genome editing therapy improves health and survival in a mouse model of methylmalonic acidemia.
Zhang S; Bastille A; Gordo S; Ramesh N; Vora J; McCarthy E; Zhang X; Frank D; Ko CW; Wu C; Walsh N; Amarwani S; Liao J; Xiong Q; Drouin L; Hebben M; Chiang K; Chau BN
PLoS One; 2022; 17(9):e0274774. PubMed ID: 36126056
[TBL] [Abstract][Full Text] [Related]
2. Promoterless, Nuclease-Free Genome Editing Confers a Growth Advantage for Corrected Hepatocytes in Mice With Methylmalonic Acidemia.
Chandler RJ; Venturoni LE; Liao J; Hubbard BT; Schneller JL; Hoffmann V; Gordo S; Zang S; Ko CW; Chau N; Chiang K; Kay MA; Barzel A; Venditti CP
Hepatology; 2021 Jun; 73(6):2223-2237. PubMed ID: 32976669
[TBL] [Abstract][Full Text] [Related]
3. Growth advantage of corrected hepatocytes in a juvenile model of methylmalonic acidemia following liver directed adeno-associated viral mediated nuclease-free genome editing.
Venturoni LE; Chandler RJ; Liao J; Hoffmann V; Ramesh N; Gordo S; Chau N; Venditti CP
Mol Genet Metab; 2022; 137(1-2):1-8. PubMed ID: 35868241
[TBL] [Abstract][Full Text] [Related]
4. Treatment of metabolic disorders using genomic technologies: Lessons from methylmalonic acidemia.
Venturoni LE; Venditti CP
J Inherit Metab Dis; 2022 Sep; 45(5):872-888. PubMed ID: 35766386
[TBL] [Abstract][Full Text] [Related]
5. Tricarboxylic acid cycle enzyme activities in a mouse model of methylmalonic aciduria.
Wongkittichote P; Cunningham G; Summar ML; Pumbo E; Forny P; Baumgartner MR; Chapman KA
Mol Genet Metab; 2019 Dec; 128(4):444-451. PubMed ID: 31648943
[TBL] [Abstract][Full Text] [Related]
6. Pre-clinical efficacy and dosing of an AAV8 vector expressing human methylmalonyl-CoA mutase in a murine model of methylmalonic acidemia (MMA).
Chandler RJ; Venditti CP
Mol Genet Metab; 2012 Nov; 107(3):617-9. PubMed ID: 23046887
[TBL] [Abstract][Full Text] [Related]
7. Development of transgenic mice containing an introduced stop codon on the human methylmalonyl-CoA mutase locus.
Buck NE; Dashnow H; Pitt JJ; Wood LR; Peters HL
PLoS One; 2012; 7(9):e44974. PubMed ID: 23024777
[TBL] [Abstract][Full Text] [Related]
8. Impaired Function of a Rare Mutation in the
Dai S; Yang Y; Li Y; Liu H
Genet Res (Camb); 2022; 2022():5611697. PubMed ID: 35919035
[TBL] [Abstract][Full Text] [Related]
9. Impaired mitophagy links mitochondrial disease to epithelial stress in methylmalonyl-CoA mutase deficiency.
Luciani A; Schumann A; Berquez M; Chen Z; Nieri D; Failli M; Debaix H; Festa BP; Tokonami N; Raimondi A; Cremonesi A; Carrella D; Forny P; Kölker S; Diomedi Camassei F; Diaz F; Moraes CT; Di Bernardo D; Baumgartner MR; Devuyst O
Nat Commun; 2020 Feb; 11(1):970. PubMed ID: 32080200
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral-mediated correction of methylmalonyl-CoA mutase deficiency in murine fibroblasts and human hepatocytes.
Chandler RJ; Tsai MS; Dorko K; Sloan J; Korson M; Freeman R; Strom S; Venditti CP
BMC Med Genet; 2007 Apr; 8():24. PubMed ID: 17470278
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers to predict disease progression and therapeutic response in isolated methylmalonic acidemia.
Manoli I; Gebremariam A; McCoy S; Pass AR; Gagné J; Hall C; Ferry S; Van Ryzin C; Sloan JL; Sacchetti E; Catesini G; Rizzo C; Martinelli D; Spada M; Dionisi-Vici C; Venditti CP
J Inherit Metab Dis; 2023 Jul; 46(4):554-572. PubMed ID: 37243446
[TBL] [Abstract][Full Text] [Related]
12. Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia.
An D; Schneller JL; Frassetto A; Liang S; Zhu X; Park JS; Theisen M; Hong SJ; Zhou J; Rajendran R; Levy B; Howell R; Besin G; Presnyak V; Sabnis S; Murphy-Benenato KE; Kumarasinghe ES; Salerno T; Mihai C; Lukacs CM; Chandler RJ; Guey LT; Venditti CP; Martini PGV
Cell Rep; 2017 Dec; 21(12):3548-3558. PubMed ID: 29262333
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing Antibodies Against Adeno-Associated Viral Capsids in Patients with mut Methylmalonic Acidemia.
Harrington EA; Sloan JL; Manoli I; Chandler RJ; Schneider M; McGuire PJ; Calcedo R; Wilson JM; Venditti CP
Hum Gene Ther; 2016 May; 27(5):345-53. PubMed ID: 26790480
[TBL] [Abstract][Full Text] [Related]
14.
Schneller JL; Lee CM; Venturoni LE; Chandler RJ; Li A; Myung S; Cradick TJ; Hurley AE; Lagor WR; Bao G; Venditti CP
Mol Ther Methods Clin Dev; 2021 Dec; 23():619-632. PubMed ID: 34901307
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and anaplerotic applications of in vitro models of propionic acidemia and methylmalonic acidemia using patient-derived primary hepatocytes.
Collado MS; Armstrong AJ; Olson M; Hoang SA; Day N; Summar M; Chapman KA; Reardon J; Figler RA; Wamhoff BR
Mol Genet Metab; 2020 Jul; 130(3):183-196. PubMed ID: 32451238
[TBL] [Abstract][Full Text] [Related]
16. Systemic gene therapy for methylmalonic acidemia using the novel adeno-associated viral vector 44.9.
Chandler RJ; Di Pasquale G; Sloan JL; McCoy S; Hubbard BT; Kilts TM; Manoli I; Chiorini JA; Venditti CP
Mol Ther Methods Clin Dev; 2022 Dec; 27():61-72. PubMed ID: 36186952
[TBL] [Abstract][Full Text] [Related]
17. Central nervous system-targeted adeno-associated virus gene therapy in methylmalonic acidemia.
May FJ; Head PE; Venturoni LE; Chandler RJ; Venditti CP
Mol Ther Methods Clin Dev; 2021 Jun; 21():765-776. PubMed ID: 34169115
[TBL] [Abstract][Full Text] [Related]
18. Long-term rescue of a lethal murine model of methylmalonic acidemia using adeno-associated viral gene therapy.
Chandler RJ; Venditti CP
Mol Ther; 2010 Jan; 18(1):11-6. PubMed ID: 19861951
[TBL] [Abstract][Full Text] [Related]
19. A study on a cohort of 301 Chinese patients with isolated methylmalonic acidemia.
Kang L; Liu Y; Shen M; Liu Y; He R; Song J; Jin Y; Li M; Zhang Y; Dong H; Liu X; Yan H; Qin J; Zheng H; Chen Y; Li D; Wei H; Zhang H; Sun L; Zhu Z; Liang D; Yang Y
J Inherit Metab Dis; 2020 May; 43(3):409-423. PubMed ID: 31622506
[TBL] [Abstract][Full Text] [Related]
20. A novel small molecule approach for the treatment of propionic and methylmalonic acidemias.
Armstrong AJ; Collado MS; Henke BR; Olson MW; Hoang SA; Hamilton CA; Pourtaheri TD; Chapman KA; Summar MM; Johns BA; Wamhoff BR; Reardon JE; Figler RA
Mol Genet Metab; 2021 May; 133(1):71-82. PubMed ID: 33741272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]